4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000054
Director sold 558 shares at an average $20.92 ($11,671)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedberg Ezra M · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Sale : show line 1 in the form 10b5-1 | −293 | $20.51 | $6,010 | 82,292 | D |
| 2026-04-02 | Sale : show line 2 in the form 10b5-1 | −265 | $21.36 | $5,661 | 82,027 | D |
| Open-market sales · 558 sh · avg $20.92 · $11,671 | ||||||
Loading xslF345X06/wk-form4_1775509382.xml…